The Acute Kidney Injury (AKI) Clinical Domain Team aims to investigate risk factors associated with kidney injury and recovery, as well as use of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) in kidney disease. Their research involves the assessment of risk factors, predictors, duration, dialysis need and timing, clinical measures, and interventions for COVID-19-related complications of the kidney. The team also collaborates with other nephrology domain experts.
\r\n\r\nTeam meets every Wednesday at 4:00 PM ET. Please email n3c-tt-akiarbace@googlegroups.com to be added to the calendar invite.
\r\n", "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/369", "leads": [ { "url": "https://covid.cd2h.org/node/410", "name": "Ken Wilkins, PhD", "delta": 0, "institution": "NIDDK" }, { "url": "https://covid.cd2h.org/node/411", "name": " Harold Lehmann, MD, PhD", "delta": 1, "institution": "Johns Hopkins University" } ], "title": "Applicable Data Methods & Standards (ADM&S)", "summary": "The Applicable Data Methods & Standards (ADM&S) Domain Team aims to explore which data methods & standards are applicable to the range of questions researchers will pursue within N3C.", "description": "The Applicable Data Methods & Standards (ADM&S or \"AD-MetS\") Domain Team aims to explore which data methods & standards are applicable to the range of questions researchers will pursue within N3C, with some near-term and longer-term activities outlined below. A mission statement is currently being formed around thematic goals:
\r\n\r\nTeam meetings are held every Wednesday at 8:00am PT/11:00am ET. To join this call, please register here.
\r\n\r\n\r\n", "cross_cutting": true }, { "url": "https://covid.cd2h.org/node/557", "leads": [ { "url": "https://covid.cd2h.org/node/556", "name": "J.W. Awori Hayanga, MD, MPH,FRCS, FACS, FCCP", "delta": 0, "institution": "West Virginia University School of Medicine" } ], "title": "Cardiothoracic and Vascular Surgery", "summary": "The Cardiothoracic and Vascular Surgery Domain Team seeks to establish risk factors for morbidity and mortality in COVID-19 patients who underwent cardiothoracic surgical procedures.", "description": null, "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/438", "leads": [ { "url": "https://covid.cd2h.org/node/584", "name": "Scott Chapman, PharmD", "delta": 0, "institution": "University of Minnesota" }, { "url": "https://covid.cd2h.org/node/585", "name": "Brijesh Patel, DO", "delta": 1, "institution": "West Virginia University" } ], "title": "Cardiovascular Disease", "summary": "The mission of the Cardiovascular Disease Clinical Domain Team is to better understand the effects of COVID-19 on patients with new and existing cardiovascular disease.", "description": "
The mission of the Cardiovascular Disease Clinical Domain Team is to better understand the effects of COVID-19 on patients with new and existing cardiovascular disease including, but not limited to, acute myocardial infarction, congestive heart failure, stroke, and coronary artery disease to determine the effect of COVID-19 on outcomes including mortality, hospitalization, and access to care.
\r\n\r\n\r\n", "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/487", "leads": [ { "url": "https://covid.cd2h.org/node/484", "name": "Nasia Safdar, MD, PhD", "delta": 0, "institution": "University of Wisconsin - Madison" }, { "url": "https://covid.cd2h.org/node/485", "name": "Jomol Mathew, PhD", "delta": 1, "institution": "University of Wisconsin - Madison" }, { "url": "https://covid.cd2h.org/node/486", "name": "Saiju Pyarajan, PhD", "delta": 2, "institution": "Brigham and Women's Hospital, Harvard Medical School" } ], "title": "COVID-19 Vaccination", "summary": "The goal of this Domain Team is to study the impact of vaccinations for combating the COVID-19 pandemic.", "description": null, "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/534", "leads": [ { "url": "https://covid.cd2h.org/node/533", "name": "Jin Ge, MD, MBA", "delta": 0, "institution": "University of California, San Francisco" } ], "title": "Gastroenterology and Hepatology (GI/Liver)", "summary": "The Gastroenterology and Hepatology Domain Team aims to gain a better understanding of how SARS-Cov-2 infection affects patient populations with chronic gastrointestinal and liver diseases.", "description": null, "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/364", "leads": [ { "url": "https://covid.cd2h.org/node/361", "name": "Randeep Jawa, MD", "delta": 0, "institution": "Stony Brook Medicine" }, { "url": "https://covid.cd2h.org/node/372", "name": "Vignesh Subbian, PhD", "delta": 1, "institution": "University of Arizona" }, { "url": "https://covid.cd2h.org/node/360", "name": "Rishi Kamaleswaran, PhD", "delta": 2, "institution": "Emory University" }, { "url": "https://covid.cd2h.org/node/359", "name": "Greg Martin, MD, MSc", "delta": 3, "institution": "Emory University" } ], "title": "Critical Care, Ventilation, Multi-organ Dysfunction Syndrome (MODS)", "summary": "The Critical Care/Ventilation/Multi-organ Dysfunction Syndrome (MODS) Clinical Domain Team aims to define and characterize the phenotypes of multiple organ dysfunction and complex disease trajectories among hospitalized patients with COVID-19.", "description": "The Critical Care/Ventilation/Multi-organ Dysfunction Syndrome (MODS) Clinical Domain Team, one of few ?joint? N3C Domain Teams, aims to better understand and characterize complex disease trajectories including multiple organ dysfunction, along with determination of treatment efficacies to improve outcomes in critically ill patients with COVID-19. The vision of the Critical Care/Ventilation/MODS Domain Team is to understand the pathophysiology of the SARS-CoV-2 virus on single and multi-organ systems, and what determines optimal treatment strategies affecting short- and longer-term outcomes of critically ill COVID-19 patients. The ventilation subgroup is focused on defining critical care cohorts based on ventilation strategies, as well as studying clinical outcomes on intubated patients versus those not intubated. The MODS subgroup focuses on characterizing multi-organ dysfunction as a temporal trajectory and probabilistic process.
\r\n\r\nBoth subgroups are actively soliciting members to join and contribute to the goals and mission of this highly unique domain team.
\r\n\r\nTeam meeting every other Thursday from 1:00 - 1:45 pm ET. Please email n3c-tt-decompensation-multi-organ-dysfunction@googlegroups.com to be added to the calendar invite.
\r\n", "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/340", "leads": [ { "url": "https://covid.cd2h.org/node/589", "name": " Carolyn Bramante, MD, MPH", "delta": 0, "institution": "University of Minnesota" }, { "url": "https://covid.cd2h.org/node/347", "name": "John Buse, MD", "delta": 1, "institution": "University of North Carolina" } ], "title": "Diabetes & Obesity", "summary": "The Diabetes and Obesity Clinical Domain Team aims to address questions regarding who among people with diabetes and/or obesity are likely to experience poor outcomes in the setting of COVID-19.", "description": "The Diabetes and Obesity Clinical Domain Team aims to address questions regarding who among people with diabetes and/or obesity are likely to experience poor outcomes in the setting of COVID-19. Though hundreds of papers have been written on this topic, most involve small sample size, single centers, international data resources or other characteristics that leave unanswered questions. Three protocols have been drafted to examine: (1) Effect of glycemic control on COVID-19 outcomes, (2) COVID-19 outcomes as a function of metformin use, and (3) Comparative effectiveness research on COVID-19 outcomes as a function of antihyperglycemic medication use at baseline. The overall goal is to evaluate baseline factors for effects on COVID-19 outcomes in diabetes.
\r\n\r\nTeam meeting on the 4th Thursday of the month at 9:00am ET. Please email n3c-tt-diabetes@googlegroups.com to be added to the calendar invite.
\r\n", "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/595", "leads": [ { "url": "https://covid.cd2h.org/node/517", "name": "Shawn O'Neil, PhD", "delta": 0, "institution": "Oregon State University" }, { "url": "https://covid.cd2h.org/node/596", "name": "Karen Crowley, PhD", "delta": 1, "institution": "Brown University" } ], "title": "Education and Training", "summary": "The Education and Training Domain Team will house education-related data use requests and provide support to mentors, instructors, and learners.", "description": null, "cross_cutting": true }, { "url": "https://covid.cd2h.org/node/365", "leads": [ { "url": "https://covid.cd2h.org/node/357", "name": "Soko Setoguchi, MD, DrPH, FISPE", "delta": 0, "institution": "Rutgers University" }, { "url": "https://covid.cd2h.org/node/371", "name": "Jessica Islam, PhD, MPH", "delta": 1, "institution": "Lineberger Comprehensive Cancer Center" } ], "title": "Elder Impact", "summary": "The Elder Impact Clinical Domain Team aims to complete a descriptive study to illustrate the impacts of COVID-19 on older adults and those with dementia/functional limitations.", "description": "The Elder Impact Clinical Domain Team aims to complete a descriptive study to illustrate the impacts of COVID-19 on older adults and those with dementia/functional limitations. This includes (1) the use and safety of available COVID therapies in older patients, (2) the severity of COVID-19 among older adults with and without chronic diseases, and (3) the mental health impact of the COVID-19 pandemic on older adults.
\r\n\r\nTeam meeting every other Thursday at 12:00pm ET. Please email n3c-tt-elder-impact@googlegroups.com to be added to the calendar invite.
\r\n", "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/510", "leads": [ { "url": "https://covid.cd2h.org/node/509", "name": "Cavin Ward-Caviness, PhD", "delta": 0, "institution": "US Environmental Protection Agency" } ], "title": "Environmental Health", "summary": "The Environmental Health Domain Team aims to study and understand the impact of environmental exposures on post-acute sequelae of COVID (PASC), also known as Long COVID, and other COVID-19 phenotypes.", "description": null, "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/439", "leads": null, "title": "Genomics", "summary": "The Genomics Domain Team will explore issues related to genomics and COVID-19.", "description": "The Genomics Domain Team will explore issues related to genomics and COVID-19. More details on specific goals and leadership coming soon.
\r\n\r\nPending.
\r\n", "cross_cutting": true }, { "url": "https://covid.cd2h.org/node/626", "leads": [ { "url": "https://covid.cd2h.org/node/625", "name": "Brian Hendricks, PhD", "delta": 0, "institution": "West Virginia University" } ], "title": "GIS and Spatial Epidemiology", "summary": "The GIS and Spatial Epidemiology (GSE) domain team facilitates the technical implementation of basic and advanced GIS and spatial statistical methods within the N3C Enclave.", "description": null, "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/524", "leads": [ { "url": "https://covid.cd2h.org/node/522", "name": "Anjali A. Sharathkumar, MBBS, MD, MS", "delta": 0, "institution": "University of Iowa Carver College of Medicine" }, { "url": "https://covid.cd2h.org/node/523", "name": "Cliff Takemoto, MD", "delta": 1, "institution": "St. Jude Research Children's Hospital" } ], "title": "Hematology", "summary": "The goal of the Hematology Domain Team is to use the N3C Data Enclave to characterize the epidemiology, outcomes, and severity of COVID-19 in patients with a broad spectrum of hematological diseases.", "description": null, "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/378", "leads": [ { "url": "https://covid.cd2h.org/node/131", "name": "Joel Saltz, MD, PhD", "delta": 0, "institution": "Stony Brook University" }, { "url": "https://covid.cd2h.org/node/355", "name": "Fred Prior, PhD", "delta": 1, "institution": "University of Arkansas for Medical Sciences" } ], "title": "Imaging", "summary": "The Imaging Domain Team seeks to explore the knowledge that can be gained about the relationship between radiological imaging features and COVID-19 as well as to identify and better understand what variables in this space can be used to predict disease and outcome characteristics.", "description": "The clinical research objectives of this group are to explore (1) knowledge that can be gained about the relationship between radiological imaging features and COVID-19 clinical course, clinical manifestations, comorbidities, (2) the ability of radiological images combined with other clinical and demographic variables to predict disease course, severity, sequelae, and long-term disease impact, and (3) the ability of combined radiology imaging information and clinical and demographic variables to predict disease course, organ system involvement, severity, and development of chronic post-COVID-19 syndromes. The infrastructure development objectives of this group are to develop software infrastructure to link outside sources of images and imaging features to the N3C Data Enclave, as well as to be an early adopter of the hashing method for linking TCIA imaging data to N3C data.
\r\n\r\nPending.
\r\n", "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/341", "leads": [ { "url": "https://covid.cd2h.org/node/348", "name": "Amy Olex, PhD", "delta": 0, "institution": "Virginia Commonwealth University" }, { "url": "https://covid.cd2h.org/node/351", "name": "Rena Patel, MD, MPH", "delta": 1, "institution": "University of Washington Medicine" } ], "title": "Immunosuppressed or Compromised (ISC)", "summary": "The Immunosuppressed/Compromised (ISC) Clinical Domain Team aims to gain a better understanding of how COVID-19 affects patient populations with suppressed or compromised immune systems.", "description": "The Immunosuppressed/Compromised (ISC) Clinical Domain Team aims to gain a better understanding of how COVID-19 affects patient populations with suppressed or compromised immune systems. The initial research will focus on a subset of target populations, including persons with HIV, solid organ transplant patients, and patients with autoimmune disorders, including skin diseases such as atopic dermatitis and eczema. The team will also identify areas of research for the ISC populations that will require additional in-depth study at a level that the N3C data may not be able to provide. Through this research, a better understanding will be gained for how various types, levels, and durations of immunosuppression or compromise contribute towards ISC patient outcomes upon COVID-19 infection.
\r\n\r\nTeam meetings are held quarterly. See the exact dates/times and register for meetings here.
\r\n", "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/550", "leads": [ { "url": "https://covid.cd2h.org/node/549", "name": "Lesley Cottrell, PhD", "delta": 0, "institution": "West Virginia University" } ], "title": "Lifespan Disabilities", "summary": "The mission of the Lifespan Disabilities Domain Team is to advance practices and policies that improve the education, access, and health of all people with developmental and other disabilities.", "description": "The mission of the Lifespan Disabilities Domain Team is to advance practices and policies that improve the education, access, and health of all people with developmental and other disabilities, as well as their families, by examining extent to which individuals with disabilities have been affected by COVID-19 diagnoses and access to appropriate treatments and follow up.
\r\n\r\nMeeting time: The third Friday of each month at 10:00am PT / 1:00pm ET.
\r\n", "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/431", "leads": [ { "url": "https://covid.cd2h.org/node/117", "name": "Peter Robinson, MD, MSc", "delta": 0, "institution": "Jackson Laboratory" } ], "title": "Machine Learning (ML)", "summary": "The purpose of the Machine Learning (ML) Domain Team is to develop code and documentation to illustrate ML best practices in the N3C Data Enclave and to collaborate on selected ML topics.", "description": "The purpose of the Machine Learning (ML) Domain Team is to develop code and documentation to illustrate ML best practices in the N3C Data Enclave and to collaborate on selected ML topics, such as ML standard operating procedures, graph-based ML, generalizability/racial biases in ML.
\r\n\r\nTeam meetings are held on Mondays at 9:00am PT/12:00pm ET. Please email n3c-ml@googlegroups.com to be added to the calendar invite.
\r\n", "cross_cutting": true }, { "url": "https://covid.cd2h.org/node/500", "leads": [ { "url": "https://covid.cd2h.org/node/499", "name": "Joel Gagnier, ND, MSc, PhD", "delta": 0, "institution": "University of Michigan, Michigan Medicine" } ], "title": "Musculoskeletal (MSK)", "summary": "The Musculoskeletal Clinical Domain Team aims to characterize musculoskeletal (MSK) symptoms in acute and long-COVID-19.", "description": "The Musculoskeletal Clinical Domain Team aims to characterize musculoskeletal (MSK) symptoms in acute and long-COVID-19, identify predictors of new MSK symptoms or aggravation of pre-existing MSK conditions, develop relevant phenotypes, and establish core domains and core outcome measurement sets.
\r\n\r\nTeam meeting TBD.
\r\n", "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/445", "leads": [ { "url": "https://covid.cd2h.org/node/495", "name": "Andrew Southerland, MD, MSc", "delta": 0, "institution": "University of Virginia (UVA) Health" }, { "url": "https://covid.cd2h.org/node/488", "name": "Johanna Loomba, ME, CCRC", "delta": 1, "institution": "University of Virginia (iTHRIV) Health System" }, { "url": "https://covid.cd2h.org/node/496", "name": "Don Brown, PhD", "delta": 2, "institution": "University of Virginia (UVA) School of Data Science" }, { "url": "https://covid.cd2h.org/node/497", "name": "Ofer Sadan, MD, PhD", "delta": 3, "institution": "Emory University School of Medicine" } ], "title": "Neurology", "summary": "The Neurology Clinical Domain Team will explore associations between COVID-19 and neurological disease, including associated neurologic symptoms and disease-related neurologic outcomes.", "description": "The mission of the Neurology Clinical Domain Team is to explore associations between COVID-19 and neurological disease, including associated neurologic symptoms and disease-related neurologic outcomes. Ultimately, we hope to identify relevant biomarkers and possible treatments to prevent neurological injury as a sequela of SARS-CoV-2 infection, both stroke and non-stroke related.
\r\n\r\nTeam meetings are held every other Monday at 1:00pm ET. Please email n3c-dt-neurology@googlegroups.com to be added to the calendar invite.
\r\n\r\nNeurology Domain Team meetings will focus on topics that can benefit the research community at large by teaching N3C analytics skills while garnering community input on study and analytics design in this domain.
\r\n", "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/539", "leads": [ { "url": "https://covid.cd2h.org/node/538", "name": "Kenrick Dwain Cato, PhD, RN, FAAN, CPHIMS", "delta": 0, "institution": "Columbia University School of Nursing" } ], "title": "Nursing", "summary": "The Nursing Domain Team aims to apply the holistic perspective of nursing science and related fields to N3C activities through generation of project ideas, analysis of N3C data, identification of data gaps, and generation of resources.\r\n\r\n", "description": null, "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/440", "leads": [ { "url": "https://covid.cd2h.org/node/199", "name": "Andrew Williams, PhD", "delta": 0, "institution": "Tufts University" }, { "url": "https://covid.cd2h.org/node/599", "name": "Tiffany Callahan, PhD", "delta": 1, "institution": null } ], "title": "OMOP to OBO", "summary": "Linking the observations in EHRs with related biomedical knowledge will greatly expand the scope of EHR-based research. The goal of this working group is to demonstrate the use of these mappings in support of important new investigations of COVID-19.", "description": null, "cross_cutting": true }, { "url": "https://covid.cd2h.org/node/367", "leads": [ { "url": "https://covid.cd2h.org/node/356", "name": "Umit Topaloglu, PhD", "delta": 0, "institution": "Wake Forest University" }, { "url": "https://covid.cd2h.org/node/398", "name": "Benjamin Bates, MD", "delta": 1, "institution": "Rutgers University" }, { "url": "https://covid.cd2h.org/node/508", "name": "Noha Sharafeldin, MBBCh, MSc, PhD ", "delta": 2, "institution": "The University of Alabama at Birmingham" } ], "title": "Oncology", "summary": "The Oncology Clinical Domain Team is studying outcomes of cancer patients who contract COVID-19.", "description": "
The Oncology Clinical Domain Team is studying outcomes of cancer patients who contract COVID-19. Cancer phenotypes and concept sets using OMOP data definitions in the N3C Data Enclave are continuously being developed and refined. We are utilizing this data to (1) characterize a cohort of COVID-19 patients with cancer within N3C; (2) identify cancer subpopulations and predictors of increased risk of death or severe complications due to COVID-19; (3) study the prevalence of symptoms and complications caused by the COVID-19 sequelae, including post-acute sequelae; (4) examine the impact of COVID-19 on cancer care, and (5) investigate the effects of cancer therapies and interventions on outcomes of patients infected with COVID-19. Our team includes a diverse range of clinical, epidemiological informatics data and logic liaisons, and statistical expertise.
\r\n\r\nTeam meeting every Tuesday 8:00am PT/11:00am ET. Please email n3c-tt-oncology@googlegroups.com for meeting invite.
\r\n\r\n\r\n", "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/598", "leads": [ { "url": "https://covid.cd2h.org/node/785", "name": "Ye Lin, MS, DMD", "delta": 0, "institution": "The State University of New York at Buffalo School of Dental Medicine" }, { "url": "https://covid.cd2h.org/node/786", "name": "Chen Liang, PhD, FAMIA", "delta": 1, "institution": "University of South Carolina" } ], "title": "Oral Health", "summary": "The Oral Health Domain Team is focused on understanding the impact of COVID-19 and Long COVID on the clinical progression, outcomes, and treatment optimization of dental patients.", "description": "
The Oral Health Domain Team is focused on understanding the impact of COVID-19 and Long COVID on the clinical progression, outcomes, and treatment optimization of dental patients. Our prioritized research will include 1) identifying emerging research questions and vulnerable populations in oral health peri pandemic and during the post-pandemic recovery, 2) developing electronic EHR phenotyping algorithms specific for oral diseases, 3) examining epidemiology of oral complications relating to COVID-19, 4) examining the impact of COVID-19 on oral diseases and risk factors, and 5) identifying clinical evidence for better treatments.
\r\n\r\nTeam Meeting: 2nd Friday of the month at 12:30pm/3:30ET. Please email n3c-oral-health-dt@ctsa.io to join the Domain Team and get the meeting information.
\r\n", "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/521", "leads": [ { "url": "https://covid.cd2h.org/node/518", "name": "Meredith Adams MD, MS, FASA, FAMIA ", "delta": 0, "institution": "Wake Forest School of Medicine " }, { "url": "https://covid.cd2h.org/node/352", "name": "Elaine Hill, PhD", "delta": 1, "institution": "University of Rochester Medical Center" }, { "url": "https://covid.cd2h.org/node/519", "name": "Robert Hurley, MD, PhD", "delta": 2, "institution": "Wake Forest Baptist Health" }, { "url": "https://covid.cd2h.org/node/356", "name": "Umit Topaloglu, PhD", "delta": 3, "institution": "Wake Forest University" }, { "url": "https://covid.cd2h.org/node/520", "name": "Jaylyn Clark, PhD", "delta": 4, "institution": "Wake Forest Baptist Health" } ], "title": "Pain, Substance Use Disorder, and Behavioral Health", "summary": "The Pain, Substance Use Disorder, and Behavioral Health team aims to answer questions regarding the impact of COVID-19 on pain, substance use, and mood.", "description": null, "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/373", "leads": [ { "url": "https://covid.cd2h.org/node/546", "name": " Lee Allan Pyles, MD, MS", "delta": 0, "institution": "West Virginia University" } ], "title": "Pediatrics", "summary": "The Pediatrics Clinical Domain Team aims to study the unique impact of COVID-19 on children from birth to young adulthood.", "description": "Meeting Time: 4th Monday of each month at 3pm EST
\r\n\r\nThe Pediatrics Clinical Domain Team aims to study the unique impact of COVID-19 on children from birth to young adulthood.
\r\n\r\nPlease email n3c-tt-peds@googlegroups.com for meeting invite.
\r\n", "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/476", "leads": [ { "url": "https://covid.cd2h.org/node/475", "name": "Jami Pincavitch, MD, MAS", "delta": 0, "institution": "West Virginia University" } ], "title": "Perioperative", "summary": "The Perioperative Domain Team is focused on understanding the impact of COVID-19 on the treatment and outcomes of surgical patients.", "description": "The Perioperative Domain Team is focused on understanding the impact of COVID-19 on the treatment and outcomes of surgical patients. The domain team?s goal is to better understand the role COVID-19 plays in relation to the management of surgical patients. The Perioperative Domain Team seeks to develop evidence that is directly relevant to the perioperative surgical complications post-COVID diagnosis. This information may provide surgical teams a better understanding of the associated risks and implement plans that improve surgical outcomes.
\r\n\r\nMeeting time: Team meetings take place on the 2nd and 4th Friday of the month at 10:00am PT/1:00pm ET.
\r\n", "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/368", "leads": [ { "url": "https://covid.cd2h.org/node/363", "name": "Caleb Alexander, MD", "delta": 0, "institution": "Johns Hopkins Medicine" }, { "url": "https://covid.cd2h.org/node/362", "name": "Hemalkumar Mehta, PhD", "delta": 1, "institution": "Johns Hopkins Bloomberg School of Public Health" } ], "title": "Pharmacoepidemiology", "summary": "The goal of the Pharmacoepidemiology Clinical Domain Team is to evaluate important, empirically testable hypotheses regarding the use, safety, and effectiveness of therapies for COVID-19 using a limited dataset from the N3C.", "description": "The Pharmacoepidemiology Clinical Domain Team aims to help design the best scenarios for drugs already in use and to provide support for the best possible trials. The overall goal is to evaluate important, empirically testable hypotheses regarding the use, safety, and effectiveness of therapies for treating COVID-19 using a limited dataset from the N3C Data Enclave. These data will provide urgently needed information for deploying therapeutic agents to treat patients with COVID-19 infection.
\r\n\r\nTeam meetings are held every other Monday at 4:00pm ET. Please email n3c-tt-pharmacoepidemiology@googlegroups.com to be added to the calendar invite.
\r\n", "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/344", "leads": [ { "url": "https://covid.cd2h.org/node/349", "name": "Dan Housman, BSc", "delta": 0, "institution": "Graticule Life" }, { "url": "https://covid.cd2h.org/node/350", "name": "Lavance Northington", "delta": 1, "institution": "Cellgen Technologies" } ], "title": "Pharma - Commercial", "summary": "The vision of the Pharma-Commercial Domain Team is to maximize engagement with commercial groups to support the increased use and utility of N3C resources and community for research on COVID-19.", "description": "The vision of the Pharma-Commercial Domain Team is to maximize engagement with commercial groups to support the increased use and utility of N3C resources and community for research on COVID-19. Because the effort is not related to a specific scientific objective, the focus is mainly on enablement vs. specific scientific research questions.
\r\n\r\nTeam meeting every Monday at 3:00pm ET. Please register here.
\r\n", "cross_cutting": true }, { "url": "https://covid.cd2h.org/node/342", "leads": [ { "url": "https://covid.cd2h.org/node/352", "name": "Elaine Hill, PhD", "delta": 0, "institution": "University of Rochester Medical Center" }, { "url": "https://covid.cd2h.org/node/351", "name": "Rena Patel, MD, MPH", "delta": 1, "institution": "University of Washington Medicine" } ], "title": "Pregnancy", "summary": "The Pregnancy Clinical Domain Team aims to leverage N3C data to gain insights into pressing COVID-19 questions around pregnancy.", "description": "The Pregnancy Clinical Domain Team aims to leverage N3C data to gain insights into pressing COVID-19 questions around pregnancy. The goal is to understand incidence, timing, and severity in pregnant women, maternal and infant outcomes, and the associated characteristics (clinical, demographic, environmental.)
\r\n\r\nTeam meetings are held on Mondays at 1:00pm PT/4:00pm ET.
\r\n", "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/449", "leads": [ { "url": "https://covid.cd2h.org/node/455", "name": "William Hillegass, MD, PhD", "delta": 0, "institution": "University of Mississippi Medical Center" }, { "url": "https://covid.cd2h.org/node/456", "name": "Will Beasley, PhD", "delta": 1, "institution": "University of Oklahoma Health Sciences Center" }, { "url": "https://covid.cd2h.org/node/489", "name": "Kimberly Murray, MPP", "delta": 2, "institution": "Maine Medical Center Research Institute" }, { "url": "https://covid.cd2h.org/node/458", "name": "Jerrod Anzalone, MS", "delta": 3, "institution": "University of Nebraska Medical Center" } ], "title": "Rural Health ", "summary": "The Rural Health Domain Team seeks to understand the epidemiology, utilization, treatment, and outcomes of the COVID-19 pandemic in rural communities. The overarching goal is to develop better evidence for potential differences in the COVID-19 epidemic response and outcomes for rural health care centers and rural dwellers.", "description": "The Rural Health Domain Team seeks to understand the epidemiology, utilization, treatment, and outcomes of the COVID-19 pandemic in rural communities. The overarching goal is to develop better evidence for potential differences in the COVID-19 epidemic response and outcomes for rural health care centers and rural dwellers. Studying the at-risk populations and unique challenges faced by rural communities during and after the pandemic may provide opportunities for improving rural health and health care.
\r\n\r\nMeeting time: Team meetings are held at 4:00 pm EST on the first Monday of the month starting 01/03/22. Please email n3c-dt-rural-health@googlegroups.com to be added to the calendar invite.
\r\n", "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/529", "leads": [ { "url": "https://covid.cd2h.org/node/528", "name": "Diego Mazzotti, PhD", "delta": 0, "institution": "The University of Kansas Medical Center" }, { "url": "https://covid.cd2h.org/node/530", "name": "Eilis Boudreau, MD, PhD", "delta": 1, "institution": "Oregon Health & Science University" } ], "title": "Sleep", "summary": "The goal of the Sleep Domain Team is to support the design and execution of studies that are leveraging sleep disorders and related phenotypes. ", "description": null, "cross_cutting": false }, { "url": "https://covid.cd2h.org/node/343", "leads": [ { "url": "https://covid.cd2h.org/node/353", "name": "Charisse Madlock-Brown, PhD, MLS", "delta": 0, "institution": "University of Tennessee Health Science Center" }, { "url": "https://covid.cd2h.org/node/112", "name": "Adam Wilcox, PhD", "delta": 1, "institution": "Washington University in St. Louis" } ], "title": "Social Determinants of Health (SDoH)", "summary": "The goal of the Social Determinants of Health (SDoH) Clinical Domain Team is to identify at least three questions that either validate current research or answer new questions for the following categories: local policy around COVID-19, impact of groups experiencing resource challenges, and impact of the pandemic on inequalities.", "description": "The goal of the Social Determinants of Health (SDoH) Clinical Domain Team is to identify at least three questions that either validate current research or answer new questions for the following categories: local policy around COVID-19, impact of groups experiencing resource challenges, and impact of the pandemic on inequalities.
\r\n\r\nTeam meetings are held every other Wednesday at 12:00pm PT/3:00pm ET. Please email n3c-tt-sdoh@googlegroups.com to be added to the calendar invite.
\r\n", "cross_cutting": false } ]